Evidence map›Paper›PMID 39304943›Full record

ReviewVirology journal2024

The RNA-binding proteins regulate innate antiviral immune signaling by modulating pattern recognition receptors.

Jianguo Li, Jingge Yu, Ao Shen, Suwen Lai, Zhiping Liu, Tian-Sheng He

Abstract readReview
In one paragraph

Review in Virology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianguo Li *School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.
Jingge Yu *School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.
Ao ShenSchool of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.
Suwen LaiSchool of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China.
Zhiping LiuSchool of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China. Zhiping.Liu@gmu.edu.cn.
Tian-Sheng HeSchool of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, China. hetiansheng361@163.com.

Funding

Doctoral startup fund of Gannan Medical University QD202126National Natural Science Foundation of China 82201952Natural Science Foundation of Jiangxi Province 20232BAB216036
6 · The paper itself

Abstract

Viral infections pose significant threats to human health, leading to a diverse spectrum of infectious diseases. The innate immune system serves as the primary barrier against viruses and bacteria in the early stages of infection. A rapid and forceful antiviral innate immune response is triggered by distinguishing between self-nucleic acids and viral nucleic acids. RNA-binding proteins (RBPs) are a diverse group of proteins which contain specific structural motifs or domains for binding RNA molecules. In the last decade, numerous of studies have outlined that RBPs influence viral replication via diverse mechanisms, directly recognizing viral nucleic acids and modulating the activity of pattern recognition receptors (PRRs). In this review, we summarize the functions of RBPs in regulation of host-virus interplay by controlling the activation of PRRs, such as RIG-I, MDA5, cGAS and TLR3. RBPs are instrumental in facilitating the identification of viral RNA or DNA, as well as viral structural proteins within the cellular cytoplasm and nucleus, functioning as co-receptor elements. On the other hand, RBPs are capable of orchestrating the activation of PRRs and facilitating the transmission of antiviral signals to downstream adaptor proteins by post-translational modifications or aggregation. Gaining a deeper comprehension of the interaction between the host and viruses is crucial for the development of novel therapeutics targeting viral infections.

Indexed as

Immunity, InnateReceptors, Pattern RecognitionRNA-Binding ProteinsSignal TransductionAnimalsHost-Pathogen InteractionsHumansRNA, ViralVirus DiseasesVirusesVirus ReplicationReceptors, Pattern RecognitionRNA-Binding ProteinsRNA, ViralHost-virus interplayInnate immunityPattern recognition receptorsRNA-binding proteins

Identifiers

PMID39304943
PMCPMC11414252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.